Literature DB >> 17943023

Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy.

Daniela Virgintino1, Ugur Ozerdem, Francesco Girolamo, Luisa Roncali, William B Stallcup, Roberto Perris.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17943023      PMCID: PMC2679116          DOI: 10.1159/000109965

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


× No keyword cloud information.
  12 in total

1.  Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells.

Authors:  Iiro Rajantie; Maritta Ilmonen; Agne Alminaite; Ugur Ozerdem; Kari Alitalo; Petri Salven
Journal:  Blood       Date:  2004-06-10       Impact factor: 22.113

2.  PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival.

Authors:  Steven Song; Andrew J Ewald; William Stallcup; Zena Werb; Gabriele Bergers
Journal:  Nat Cell Biol       Date:  2005-08-21       Impact factor: 28.824

Review 3.  Pericytes and vascular stability.

Authors:  Desiree von Tell; Annika Armulik; Christer Betsholtz
Journal:  Exp Cell Res       Date:  2005-11-21       Impact factor: 3.905

4.  Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis.

Authors:  Ugur Ozerdem; Kari Alitalo; Petri Salven; Andrew Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

5.  Platelet-derived growth factor B retention is essential for development of normal structure and function of conduit vessels and capillaries.

Authors:  Henrik C Nyström; Per Lindblom; Anna Wickman; Irene Andersson; Jenny Norlin; Jenny Fäldt; Per Lindahl; Ole Skøtt; Mattias Bjarnegård; Sharyn M Fitzgerald; Kenneth Caidahl; Li-ming Gan; Christer Betsholtz; Göran Bergström
Journal:  Cardiovasc Res       Date:  2006-05-25       Impact factor: 10.787

6.  A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.

Authors:  Kristian Pietras; Douglas Hanahan
Journal:  J Clin Oncol       Date:  2004-11-22       Impact factor: 44.544

Review 7.  Endothelial progenitor cells: precursors for angiogenesis.

Authors:  Rohit Khurana; Michael Simons
Journal:  Semin Thorac Cardiovasc Surg       Date:  2003-07

Review 8.  Tumorigenesis and the angiogenic switch.

Authors:  Gabriele Bergers; Laura E Benjamin
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

9.  Early contribution of pericytes to angiogenic sprouting and tube formation.

Authors:  Ugur Ozerdem; William B Stallcup
Journal:  Angiogenesis       Date:  2003       Impact factor: 9.596

10.  An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis.

Authors:  Daniela Virgintino; Francesco Girolamo; Mariella Errede; Carmen Capobianco; David Robertson; William B Stallcup; Roberto Perris; Luisa Roncali
Journal:  Angiogenesis       Date:  2007-01-17       Impact factor: 9.596

View more
  13 in total

Review 1.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

2.  Endothelial sphingosine kinase/SPNS2 axis is critical for vessel-like formation by human mesoangioblasts.

Authors:  Anna Laurenzana; Francesca Cencetti; Simona Serratì; Gennaro Bruno; Lukasz Japtok; Francesca Bianchini; Eugenio Torre; Gabriella Fibbi; Mario Del Rosso; Paola Bruni; Chiara Donati
Journal:  J Mol Med (Berl)       Date:  2015-05-09       Impact factor: 4.599

Review 3.  Central Nervous System Pericytes Contribute to Health and Disease.

Authors:  Francesco Girolamo; Mariella Errede; Antonella Bizzoca; Daniela Virgintino; Domenico Ribatti
Journal:  Cells       Date:  2022-05-20       Impact factor: 7.666

4.  Ischemia/Reperfusion-induced neovascularization in the cerebral cortex of the ovine fetus.

Authors:  Daniela Virgintino; Francesco Girolamo; Marco Rizzi; Nigar Ahmedli; Grazyna B Sadowska; Edward G Stopa; Jiyong Zhang; Barbara S Stonestreet
Journal:  J Neuropathol Exp Neurol       Date:  2014-06       Impact factor: 3.685

5.  Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells.

Authors:  Sabrina Cattaruzza; Ugur Ozerdem; Martin Denzel; Barbara Ranscht; Pietro Bulian; Ugo Cavallaro; Daniela Zanocco; Alfonso Colombatti; William B Stallcup; Roberto Perris
Journal:  Angiogenesis       Date:  2012-11-04       Impact factor: 9.596

6.  The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival.

Authors:  Drew Bonkowski; Vladimir Katyshev; Roumen D Balabanov; Andre Borisov; Paula Dore-Duffy
Journal:  Fluids Barriers CNS       Date:  2011-01-18

7.  Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction.

Authors:  Jorge S Burns; Malthe Kristiansen; Lars P Kristensen; Kenneth H Larsen; Maria O Nielsen; Helle Christiansen; Jan Nehlin; Jens S Andersen; Moustapha Kassem
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

8.  Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets.

Authors:  Francesco Girolamo; Alice Dallatomasina; Marco Rizzi; Mariella Errede; Thomas Wälchli; Maria Teresa Mucignat; Karl Frei; Luisa Roncali; Roberto Perris; Daniela Virgintino
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

9.  Regression and persistence: remodelling in a tissue engineered axial vascular assembly.

Authors:  E Polykandriotis; S Euler; A Arkudas; G Pryymachuk; J P Beier; P Greil; A Dragu; A Lametschwandtner; U Kneser; R E Horch
Journal:  J Cell Mol Med       Date:  2009-06-23       Impact factor: 5.310

Review 10.  Theranostic impact of NG2/CSPG4 proteoglycan in cancer.

Authors:  Pier Andrea Nicolosi; Alice Dallatomasina; Roberto Perris
Journal:  Theranostics       Date:  2015-02-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.